ISTH guidelines for the diagnosis of thrombotic thrombocytopenic purpura
X Long Zheng 1 , Sara K Vesely 2 , Spero R Cataland 3 , Paul Coppo 4 ,Brian Geldziler 5 , Alfonso Iorio 6 7 , Masanori Matsumoto 8 , Reem A Mustafa 9 , Menaka Pai 7 , Gail Rock 10 , Lene Russell 11 , Rawan Tarawneh 12 ,Julie Valdes 13 ,Flora Peyvandi 1415
J Clin Med. 2021 Feb 2;10(3):536. doi: 10.3390/jcm10030536.
Thrombotic Thrombocytopenic Purpura: Pathophysiology, Diagnosis, and Management
Senthil Sukumar 1 , Bernhard Lämmle 2 3 4 , Spero R Cataland 1
Prognostic utility of ADAMTS13 activity for the atypical hemolytic uremic syndrome (aHUS) and comparison of complement serology between aHUS and thrombotic thrombocytopenic purpura
Jisu Oh, 1 Doyeun Oh , 1 Seon Ju Lee , 2 Jeong Oh Kim , 2 Nam Keun Kim, 2 So Young Chong, 1 Ji Young Huh, 3 Ross I. Baker, 4
Br J Haematol.2019 Aug;186(3):490-498.doi: 10.1111/bjh.15932.Epub 2019 May 26.
Utilizing a PLASMIC score-based approach in the management of suspected immune thrombotic thrombocytopenic purpura: a cost minimization analysis within the Harvard TMA Research Collaborative
Vivek A Upadhyay 1 2 , Benjamin P Geisler 1 2 , Lova Sun 1 2 , Lynne Uhl 2 3 , Richard M Kaufman 2 4 , Christopher Stowell 2 5 , Robert S Makar 2 5 , Pavan K Bendapudi 2 5 6 7
Diagnosis and treatment of thrombotic microangiopathy
Gemma L. Thompson 1 , 2 and David Kavanagh 1 , 2
Can J Kidney Health Dis. 2021 Apr 22;8:20543581211008707. doi: 10.1177/20543581211008707.
Making the Correct Diagnosis in Thrombotic Microangiopathy: A Narrative Review
Philip A. McFarlane, 1 Martin Bitzan, 2,3 Catherine Broome, 4 Dana Baran, 5 Jocelyn Garland, 6 Louis-Philippe Girard, 7 Kuljit Grewal , 8 Anne-Laure Lapeyraque, 9 Christopher Jordan Patriquin, 10 Katerina Pavenski, 11 and Christoph Licht 12
Res Pract Thromb Haemost. 2022 Mar; 6(3): e12708.
Thrombotic microangiopathies: An illustrated review